Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Goel

Showing results (221-230 of 245) with videos related to

Pageof 25
Sort By:
Current Oncology (Toronto, Ont.)|July 24, 2010
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable diseaseM Vickers, B Samson, B Colwell, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationRishi R Goel, Sokratis A Apostolidis, Mark M Painter, et al.
Current Oncology (Toronto, Ont.)|January 5, 2017
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016D Bossé, T Ng, C Ahmad, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018A J Hyde, R Nassabein, A AlShareef, et al.
Current Oncology (Toronto, Ont.)|March 12, 2016
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancersT Di Valentin, T Asmis, J Asselah, et al.
Cell|February 24, 2022
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumoursT Di Valentin, J Biagi, S Bourque, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Immunity|August 28, 2021
Rapid induction of antigen-specific CD4<sup>+</sup> T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationMark M Painter, Divij Mathew, Rishi R Goel, et al.
Pageof 25

Showing results (221-230 of 245) with videos related to

Sort By:
Pageof 25
Current Oncology (Toronto, Ont.)|July 24, 2010
Eastern Canadian Colorectal Cancer Consensus Conference: setting the limits of resectable diseaseM Vickers, B Samson, B Colwell, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2021
Longitudinal Analysis Reveals Distinct Antibody and Memory B Cell Responses in SARS-CoV2 Naïve and Recovered Individuals Following mRNA VaccinationRishi R Goel, Sokratis A Apostolidis, Mark M Painter, et al.
Current Oncology (Toronto, Ont.)|January 5, 2017
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016D Bossé, T Ng, C Ahmad, et al.
Current Oncology (Toronto, Ont.)|November 12, 2019
Eastern Canadian Gastrointestinal Cancer Consensus Conference 2018A J Hyde, R Nassabein, A AlShareef, et al.
Current Oncology (Toronto, Ont.)|March 12, 2016
Eastern Canadian Colorectal Cancer Consensus Conference 2013: emerging therapies in the treatment of pancreatic, rectal, and colorectal cancersT Di Valentin, T Asmis, J Asselah, et al.
Cell|February 24, 2022
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individualsKatlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell Reports|October 16, 2022
A boost with SARS-CoV-2 BNT162b2 mRNA vaccine elicits strong humoral responses independently of the interval between the first two dosesAlexandra Tauzin, Shang Yu Gong, Debashree Chatterjee, et al.
Current Oncology (Toronto, Ont.)|October 25, 2013
Eastern Canadian Colorectal Cancer Consensus Conference: standards of care for the treatment of patients with rectal, pancreatic, and gastrointestinal stromal tumours and pancreatic neuroendocrine tumoursT Di Valentin, J Biagi, S Bourque, et al.
Nature Medicine|September 15, 2021
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapySokratis A Apostolidis, Mihir Kakara, Mark M Painter, et al.
Immunity|August 28, 2021
Rapid induction of antigen-specific CD4<sup>+</sup> T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationMark M Painter, Divij Mathew, Rishi R Goel, et al.
Pageof 25